Interdisciplinary psychosocial care for families with inherited cardiovascular diseases

Trends in Cardiovascular Medicine

Volumn 26, Issue 7, 2016, Pages 647-653

  Caleshu, Colleen ^a   Kasparian, Nadine A ^b,c   Edwards, Katharine S ^a   Yeates, Laura ^d,e,f   Semsarian, Christopher ^d,e,f   Perez, Marco ^a   Ashley, Euan ^a   Turner, Christian J ^b   Knowles, Joshua W ^a   Ingles, Jodie ^d,e,f  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d CENTENARY INSTITUTE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Genetic testing; Hypertrophic cardiomyopathy; Psychological wellbeing; Quality of life

Indexed keywords

ADULT; ANXIETY; CARDIOVASCULAR DISEASE; CASE REPORT; CHILD; EXERCISE; FAMILY COUNSELING; GENETIC RISK; HEART ARREST; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INHERITANCE; MALE; MENTAL HEALTH; PATIENT DECISION MAKING; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REVIEW; SCHOOL CHILD; SUDDEN CARDIAC DEATH; WELLBEING; CARDIOVASCULAR DISEASES; COOPERATION; COPING BEHAVIOR; COST OF ILLNESS; DEATH, SUDDEN, CARDIAC; FAMILY RELATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETICS; GRIEF; INTEGRATED HEALTH CARE SYSTEM; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE; PATIENT COMPLIANCE; PHENOTYPE; PROCEDURES; PSYCHOLOGY; PSYCHOTHERAPY;

ADAPTATION, PSYCHOLOGICAL; CARDIOVASCULAR DISEASES; COOPERATIVE BEHAVIOR; COST OF ILLNESS; DEATH, SUDDEN, CARDIAC; DELIVERY OF HEALTH CARE, INTEGRATED; FAMILY RELATIONS; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GRIEF; HUMANS; INTERDISCIPLINARY COMMUNICATION; MENTAL HEALTH; PATIENT CARE TEAM; PATIENT COMPLIANCE; PHENOTYPE; PSYCHOTHERAPY; QUALITY OF LIFE;

EID: 84975116986     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2016.04.010     Document Type: Review

References (43)

1. [1] Ingles, J., Yeates, L., Semsarian, C., The emerging role of the cardiac genetic counselor. Heart Rhythm 8 (2011), 1958–1962.
2. [2] Erskine, K.E., Griffith, E., Degroat, N., Stolerman, M., Silverstein, L.B., Hidayatallah, N., et al. An interdisciplinary approach to personalized medicine: case studies from a cardiogenetics clinic. Per Med 10 (2013), 73–80.
3. [3] Watts, G.F., Gidding, S., Wierzbicki, A.S., Toth, P.P., Alonso, R., Brown, W.V., et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Eur J Prev Cardiol 22 (2015), 849–854.
4. [4] Aatre, R.D., Day, S.M., Psychological issues in genetic testing for inherited cardiovascular diseases. Circ Cardiovasc Genet 4 (2011), 81–90.
5. [5] Hamang, A., Eide, G.E., Nordin, K., Rokne, B., Bjorvatn, C., Oyen, N., Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population. BMC Med Genet, 11, 2010, 27.
6. [6] Ingles, J., Semsarian, C., The value of cardiac genetic testing. Trends Cardiovasc Med 24 (2014), 217–224.
7. [7] Asif, I.M., Johnson, S., Schmieg, J., Smith, T., Rao, A.L., Harmon, K.G., et al. The psychological impact of cardiovascular screening: the athlete's perspective. Br J Sports Med 48 (2014), 1162–1166.
8. [8] Farnsworth, M.M., Fosyth, D., Haglund, C., Ackerman, M.J., When I go in to wake them… I wonder: parental perceptions about congenital long QT syndrome. J Am Acad Nurse Pract 18 (2006), 284–290.
9. [9] Passman, R., Subacius, H., Ruo, B., Schaechter, A., Howard, A., Sears, S.F., et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 167 (2007), 2226–2232.
10. [10] James, C.A., Tichnell, C., Murray, B., Daly, A., Sears, S.F., Calkins, H., General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study. Circ Cardiovasc Genet 5 (2012), 18–24.
11. [11] Sears, S.F., Matchett, M., Conti, J.B., Effective management of ICD patient psychosocial issues and patient critical events. J Cardiovasc Electrophysiol 20 (2009), 1297–1304.
12. [12] van der Werf, C., Onderwater, A.T., van Langen, I.M., Smets, E.M., Experiences, considerations and emotions relating to cardiogenetic evaluation in relatives of young sudden cardiac death victims. Eur J Hum Genet 22 (2014), 192–196.
13. [13] Ingles, J., Spinks, C., Yeates, L., McGeechan, K., Kasparian, N., Semsarian, C., Posttraumatic stress and prolonged grief after the sudden cardiac death of a young relative. JAMA Intern Med 176 (2016), 402–405.
14. [14] Gehi, A., Haas, D., Pipkin, S., Whooley, M.A., Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 165 (2005), 2508–2513.
15. [15] Rieckmann, N., Gerin, W., Kronish, I.M., Burg, M.M., Chaplin, W.F., Kong, G., et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol 48 (2006), 2218–2222.
16. [16] Jiang, W., Kuchibhatla, M., Cuffe, M., Christopher, E., Alexander, J., Clary, G., et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 110 (2004), 3452–3456.
17. [17] Moser, D.K., The rust of life: impact of anxiety on cardiac patients. Am J Crit Care 16 (2007), 361–369.
18. [18] Ingles, J., Sarina, T., Kasparian, N., Semsarian, C., Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Int J Cardiol 168 (2013), 3779–3784.
19. [19] Kapa, S., Rotondi-Trevisan, D., Mariano, Z., Aves, T., Irvine, J., Dorian, P., et al. Psychopathology in patients with ICDs over time: results of a prospective study. Pacing Clin Electrophysiol 33 (2010), 198–208.
20. [20] Pedersen, S.S., van den Broek, K.C., Sears, S.F. Jr, Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. Pacing Clin Electrophysiol 30 (2007), 1546–1554.
21. [21] Miller, W.R., Rollnick, S., Motivational Interviewing: Preparing People For Change, 2nd ed., 2002, Guilford Press, New York, 428.
22. [22] Ingles, J., Johnson, R., Sarina, T., Yeates, L., Burns, C., Gray, B., et al. Social determinants of health in the setting of hypertrophic cardiomyopathy. Int J Cardiol. 184 (2015), 743–749.
23. [23] Lewis, K.B., Stacey, D., Matlock, D.D., Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients’ perspectives. Patient 7 (2014), 243–260.
24. [24] Matchett, M., Sears, S.F., Hazelton, G., Kirian, K., Wilson, E., Nekkanti, R., The implantable cardioverter defibrillator: its history, current psychological impact and future. Expert Rev Med Devices 6 (2009), 43–50.
25. [25] Stacey, D., Legare, F., Col, N.F., Bennett, C.L., Barry, M.J., Eden, K.B., et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev(10), 2011, CD001431 http://dx.doi.org/10.1002/14651858.CD001431.pub3.
26. [26] Hazelton, A.G., Sears, S.F., Ford, J., Cahill, J., Nekkanti, R., Deantonio, H., et al. Decisional balance among potential implantable cardioverter defibrillator recipients: development of the ICD-decision analysis scale (ICD-DAS). Pacing Clin Electrophysiol 37 (2014), 63–72.
27. [27] Yeates, L., Hunt, L., Saleh, M., Semsarian, C., Ingles, J., Poor psychological wellbeing particularly in mothers following sudden cardiac death in the young. Eur J Cardiovasc Nurs 12 (2013), 484–491.
28. [28] Rogers, C.H., Floyd, F.J., Seltzer, M.M., Greenberg, J., Hong, J., Long-term effects of the death of a child on parents’ adjustment in midlife. J Fam Psychol 22 (2008), 203–211.
29. [29] Bates, A.T., Kearney, J.A., Understanding death with limited experience in life: dying children's and adolescents’ understanding of their own terminal illness and death. Curr Opin Support Palliat Care 9 (2015), 40–45.
30. [30] Antshel, K.M., Brewster, S., Waisbren, S.E., Child and parent attributions in chronic pediatric conditions: phenylketonuria (PKU) as an exemplar. J Child Psychol Psychiatry 45 (2004), 622–630.
31. [31] Colville, G.A., Cream, P.R., Kerry, S.M., Do parents benefit from the offer of a follow-up appointment after their child's admission to intensive care? an exploratory randomised controlled trial. Intensive Crit Care Nurs 26 (2010), 146–153.
32. [32] Christiaans, I., van Langen, I.M., Birnie, E., Bonsel, G.J., Wilde, A.A., Smets, E.M., Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet A 149A:4 (2009), 602–612.
33. [33] Blumenthal, D., Causino, N., Chang, Y.C., Culpepper, L., Marder, W., Saglam, D., et al. The duration of ambulatory visits to physicians. J Fam Pract 48 (1999), 264–271.
34. [34] Glassman, A.H., O'Connor, C.M., Califf, R.M., Swedberg, K., Schwartz, P., Bigger, J.T. Jr, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. J Am Med Assoc 288 (2002), 701–709.
35. [35] Berkman, L.F., Blumenthal, J., Burg, M., Carney, R.M., Catellier, D., Cowan, M.J., et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. J Am Med Assoc 289 (2003), 3106–3116.
36. [36] Linden, W., Phillips, M.J., Leclerc, J., Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J 28 (2007), 2972–2984.
37. [37] Orth-Gomer, K., Schneiderman, N., Wang, H.X., Walldin, C., Blom, M., Jernberg, T., Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD). Circ Cardiovasc Qual Outcomes 2 (2009), 25–32.
38. [38] Gulliksson, M., Burell, G., Vessby, B., Lundin, L., Toss, H., Svardsudd, K., Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med 171 (2011), 134–140.
39. [39] Sears, S.F., Todaro, J.F., Urizar, G., Lewis, T.S., Sirois, B., Wallace, R., et al. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol 23 (2000), 939–945.
40. [40] Austin, J., Semaka, A., Hadjipavlou, G., Conceptualizing genetic counseling as psychotherapy in the era of genomic medicine. J Genet Couns 23 (2014), 903–909.
41. [41] Moorey, S., I know they are distressed. What do I do now?. Psycho-oncology 22 (2013), 1946–1952.
42. [42] Priori, S.G., Wilde, A.A., Horie, M., Cho, Y., Behr, E.R., Berul, C., et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10 (2013), 1932–1963.
43. [43] Leichsenring, F., Rabung, S., Leibing, E., The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 61 (2004), 1208–1216.